Literature DB >> 19242126

hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells.

Fangming Gao1, Jose F Ponte, Panagiotis Papageorgis, Mary Levy, Sait Ozturk, Arthur W Lambert, Hongjie Pan, Dharmaraj Chinnappan, Kuang-Hung Cheng, Arunthathi Thiagalingam, Hamid M Abdolmaleky, Sam Thiagalingam.   

Abstract

It has been universally believed that spindle assembly checkpoint (SAC) proteins which include the kinetochore proteins are involved in monitoring the faithful segregation of sister chromatids during cell division and hence defects in these proteins result in aneuploidy. Furthermore, there are multiple sources of experimental data to suggest that a defect in p53 can also promote genomic instability leading to aneuploidy. Despite these observations, a molecular basis for the prevention of aneuploidy to maintain genomic integrity upon activation of SAC has largely remained elusive. In this report, we demonstrate a novel mechanism for the maintenance of a balance between cell survival and apoptosis upon activation of SAC. We found that depletion of the outer kinetochore protein hBub1 upon activation of SAC primarily triggers early cell death mediated by p53. This phenomenon is further supported by the upregulation of p53 downstream pro-apoptotic genes, BAX and PUMA as well as a corresponding increase in the cleavage products of PARP and caspase 3, markers of apoptosis, upon depletion of hBub1 in SAC activated cells. On the other hand, as expected, concomitant loss of both hBub1 and p53 resulted in disabling of the p53 mediated cell death pathway leading to the accumulation of cells with aneuploidy/polyploidy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242126     DOI: 10.4161/cbt.8.7.7928

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  7 in total

1.  Quantitative proteome analysis of pluripotent cells by iTRAQ mass tagging reveals post-transcriptional regulation of proteins required for ES cell self-renewal.

Authors:  Robert N O'Brien; Zhouxin Shen; Kiyoshi Tachikawa; Pei Angel Lee; Steven P Briggs
Journal:  Mol Cell Proteomics       Date:  2010-05-31       Impact factor: 5.911

2.  Smad4 inactivation promotes malignancy and drug resistance of colon cancer.

Authors:  Panagiotis Papageorgis; Kuanghung Cheng; Sait Ozturk; Yi Gong; Arthur W Lambert; Hamid M Abdolmaleky; Jin-Rong Zhou; Sam Thiagalingam
Journal:  Cancer Res       Date:  2011-01-18       Impact factor: 12.701

3.  Smad signaling is required to maintain epigenetic silencing during breast cancer progression.

Authors:  Panagiotis Papageorgis; Arthur W Lambert; Sait Ozturk; Fangming Gao; Hongjie Pan; Upender Manne; Yuriy O Alekseyev; Arunthathi Thiagalingam; Hamid M Abdolmaleky; Marc Lenburg; Sam Thiagalingam
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

4.  BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells.

Authors:  Andressa Gois Morales; Julia Alejandra Pezuk; María Sol Brassesco; Jaqueline Carvalho de Oliveira; Rosane Gomes de Paula Queiroz; Hélio Rubens Machado; Carlos Gilberto Carlotti; Luciano Neder; Harley Francisco de Oliveira; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Childs Nerv Syst       Date:  2013-06-02       Impact factor: 1.475

5.  Mitotic Kinases and p53 Signaling.

Authors:  Geun-Hyoung Ha; Eun-Kyoung Yim Breuer
Journal:  Biochem Res Int       Date:  2012-07-19

6.  MicroRNA-450a-3p represses cell proliferation and regulates embryo development by regulating Bub1 expression in mouse.

Authors:  Min Luo; Yaguang Weng; Jian Tang; Min Hu; Qiang Liu; Fengbing Jiang; Dandan Yang; Chen Liu; Xiaoqin Zhan; Peipei Song; Huili Bai; Baolin Li; Qiong Shi
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

7.  Comprehensive analysis of differential expression profiles reveals potential biomarkers associated with the cell cycle and regulated by p53 in human small cell lung cancer.

Authors:  Zhong Ni; Xiting Wang; Tianchen Zhang; Linlin Li; Jianxue Li
Journal:  Exp Ther Med       Date:  2018-02-02       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.